Neurogene Inc. (NGNE)
NASDAQ: NGNE · USD
$33.6
-0.06 (-0.2%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first NGNE analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 669.5M | |
|---|---|---|
| Net income (ttm) | -98.6M | |
| EPS (ttm) | -$4.56 | |
| Shares out | 19.9M | |
| Volume | 93,077 | |
| Beta | 1.96 | |
| Price target | $81.7 | +143.2% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -98.6M
- EPS (ttm)
- -$4.56
- Market cap
- 669.5M
Fair-value bridge
- Current price
- $33.6
Analyst consensus
Recommendation
Strong Buy
Price target
$81.7
+143.2%
In the news
Latest news · NGNE
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 669.5M
- P/B
- 2.2x
Profitability
- ROE
- -37.3%
- ROA
- -23.9%
- ROIC
- -25.1%
Balance sheet
- Debt / equity
- 0.04
- Current ratio
- 13.08
- Quick ratio
- 12.90
Trading
- Beta
- 1.96
- Volume
- 93,077
- Dividend yield
- 0.0%